Keyphrases
Virus
100%
Live Attenuated
100%
Vaccine Candidate
100%
Safety Efficacy
100%
Preclinical Safety Studies
100%
Efficacy Testing
100%
Chikungunya Vaccine
100%
Stability Testing
100%
Virulence
42%
Immunogenic
28%
Chikungunya Virus (CHIKV)
28%
Viral Load
28%
AG129 Mice
28%
Attenuation
14%
Vaccine Strain
14%
Virus Challenge
14%
Human Subject Test
14%
Spleen
14%
Nonhuman Primate
14%
Pathological Lesions
14%
Weight Loss
14%
Phase III Clinical Trial
14%
Interferon Receptor
14%
Chikungunya Fever
14%
Footpad
14%
Live Attenuated Vaccine Candidate
14%
Leg muscles
14%
Incompetence
14%
Hepatic Lesion
14%
Low Viral Load
14%
Nonclinical Safety
14%
Subcutaneous Infection
14%
Massive Weight Loss
14%
Preclinical Safety
14%
Weight Stability
14%
Immunology and Microbiology
Viral Load
100%
Wild Type
66%
Chikungunya Virus
66%
interferon
33%
Attenuated Vaccine
33%
Live Vaccine
33%
Leg Muscle
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chikungunya
100%
Chikungunya Virus
66%
Clinical Trial
33%
Infection
33%
Vaccine Strain
33%
Liver Injury
33%
Live Vaccine
33%
Interferon Receptor
33%